United Therapeutics (UTHR) Tops Q4 EPS by 17c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 591.20 -1.64 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $592.84 | 52 Week High | $164.04 | |||
| Open | $587.10 | 52 Week Low | $97.52 | |||
| Day High | $593.00 | P/E | 108.08 | |||
| Day Low | $582.67 | EPS | $5.47 | |||
| Volume | 440,164 | |||||
